Addition of prednisolone and heparin in patients with failed IVF/ICSI cycles: a preliminary report of a clinical trial

Hum Fertil (Camb). 2013 Sep;16(3):207-10. doi: 10.3109/14647273.2013.803608. Epub 2013 Jul 8.

Abstract

Through a non-randomized clinical trial, we examined the theoretical benefit of the coadministration of low molecular weight heparin (LMWH) and prednisolone on pregnancy outcomes in women with previously failed IVF/ICSI cycles. Fifteen women constituted the study group, and were compared with 19 women receiving LMWH alone and another 18 women with no drugs. Our finding that the combination of the two drugs produced positive differences in terms of embryo quality, pregnancy and live birth rates points to the necessity for adequately powered randomized trials.

Publication types

  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Abortion, Spontaneous / prevention & control
  • Administration, Intravaginal
  • Administration, Oral
  • Adult
  • Anticoagulants / administration & dosage
  • Anticoagulants / pharmacology*
  • Early Termination of Clinical Trials
  • Ectogenesis*
  • Enoxaparin / administration & dosage
  • Enoxaparin / pharmacology*
  • Female
  • Fertility Agents, Female / administration & dosage
  • Fertility Agents, Female / pharmacology*
  • Fertilization in Vitro*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / pharmacology*
  • Greece / epidemiology
  • Humans
  • Infertility, Female / therapy
  • Live Birth
  • Pilot Projects
  • Prednisolone / administration & dosage
  • Prednisolone / pharmacology*
  • Pregnancy
  • Pregnancy Maintenance / drug effects
  • Pregnancy Rate
  • Sperm Injections, Intracytoplasmic

Substances

  • Anticoagulants
  • Enoxaparin
  • Fertility Agents, Female
  • Glucocorticoids
  • Prednisolone